Conclusion: The clinical effects are significantly improved by trimetazidine for treating patients with multivessel coronary disease undergoing incomplete interventional revascularization.

• 结论：在常规治疗的基础上加用曲美他嗪对冠脉多支病变血运重建不完全的患者有一定疗效。